Canaan X L.P. Cuts IDEAYA Bio Stake to 2.9% as of Dec 31

TL;DR

**Canaan X L.P. just trimmed its IDEAYA Bio stake to 2.9%, watch for potential investor sentiment shifts.**

AI Summary

Canaan X L.P. has filed an amended SC 13G/A, indicating a change in their beneficial ownership of IDEAYA Biosciences, Inc. common stock as of December 31, 2023. The filing shows Canaan X L.P. now beneficially owns 1,570,820 shares, representing 2.9% of the company's common stock. This matters to investors because it signals a notable venture capital firm's reduced stake, potentially indicating a shift in their long-term outlook on IDEAYA Biosciences, Inc.'s future performance.

Why It Matters

This filing shows a significant venture capital firm, Canaan X L.P., has reduced its ownership in IDEAYA Biosciences, Inc., which could be interpreted as a decrease in their confidence in the company's near-term prospects.

Risk Assessment

Risk Level: medium — A reduction in ownership by a major institutional investor can signal potential concerns about the company's future, increasing investment risk.

Analyst Insight

Investors should monitor IDEAYA Biosciences, Inc.'s upcoming financial reports and news for any specific reasons behind Canaan X L.P.'s reduced stake, and consider if this aligns with their own investment thesis before making any decisions.

Key Numbers

• 1,570,820 — Shares Beneficially Owned (The total number of shares of IDEAYA Biosciences, Inc. common stock beneficially owned by Canaan X L.P. as of December 31, 2023.)
• 2.9% — Percentage of Class (The percentage of IDEAYA Biosciences, Inc. common stock beneficially owned by Canaan X L.P. as of December 31, 2023.)
• December 31, 2023 — Date of Event (The date that triggered the requirement for this SC 13G/A filing.)
• $0.0001 — Par Value Per Share (The par value of IDEAYA Biosciences, Inc. common stock.)

Key Players & Entities

• Canaan X L.P. (company) — the reporting person who filed the SC 13G/A
• IDEAYA Biosciences, Inc. (company) — the subject company whose stock is being reported
• CANAAN PARTNERS X LLC (company) — a group member associated with the filing
• Cayman Islands (company) — place of organization for Canaan X L.P.

Forward-Looking Statements

• IDEAYA Biosciences, Inc. stock price may experience short-term volatility due to the perceived lack of confidence from a major institutional investor. (IDEAYA Biosciences, Inc.) — medium confidence, target: 3 months
• Other institutional investors might re-evaluate their positions in IDEAYA Biosciences, Inc. following Canaan X L.P.'s reduced stake. (IDEAYA Biosciences, Inc.) — low confidence, target: 6 months

FAQ

Key Financial Figures

• $0.0001 — Inc. (Name of Issuer) COMMON STOCK, $0.0001 PAR VALUE PER SHARE (Title of Class o

Filing Documents

• d723295dsc13ga.htm (SC 13G/A) — 65KB
• 0001193125-24-021891.txt ( ) — 67KB

Issuer

Item 1.Issuer (a) Name of Issuer: IDEAYA Biosciences, Inc. (the Issuer ) (b) Address of Issuers Principal Executive Offices: 7000 Shoreline Court Suite 350 South San Francisco, CA 94080

Filing Person

Item 2.Filing Person (a) (c) Name of Persons Filing; Address; Citizenship: (i)Canaan X L.P., a Cayman Islands limited partnership (the Fund ); and (ii)Canaan Partners X LLC, a Delaware limited liability company (the General Partner ). The address of the principal business office of each of the reporting persons is 2765 Sand Hill Road, Menlo Park, California 94025. (d) Title of Class of Securities: Common Stock, $0.0001 par value per share, (the Common Stock ) (e) CUSIP Number: 45166A 102

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a

Item 3.If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under Section 15 of the Act; (b) Bank as defined in Section 3(a)(6) of the Act; (c) Insurance company as defined in Section 3(a)(19) of the Act; (d) Investment company registered under Section 8 of the Investment Company Act of 1940; (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: CUSIP No. 45166A 102 SCHEDULE 13G Page 5 of 6 Pages

Ownership

Item 4.Ownership. (a) and (b) Amount beneficially owned: (i) The Fund directly owns 1,570,820 shares of Common Stock, which represents approximately 2.4% of the outstanding shares of Common Stock. (ii) The General Partner is the general partner of the Fund and may be deemed to beneficially own 1,570,820 shares of Common Stock, which represents approximately 2.4% of the outstanding shares of Common Stock. (c) Number of shares as to which such person has: Number of Common Stock Reporting Person (i) (ii) (iii) (iv) Canaan X L.P. 1,570,820 0 1,570,820 0 Canaan Partners X LLC 1,570,820 0 1,570,820 0 (i) Sole power to vote or direct the vote (ii) Shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of (iv) Shared power to dispose or to direct the disposition of The percent of class was calculated based on 64,459,472 shares of common stock outstanding as of November 3, 2023, as disclosed in the Issuers Quarterly Report on Form 10-Q for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on November 7, 2023. Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following. Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. CUSIP No. 45166A 102 SCHEDULE 13G Page 6 of 6 Pages SIGNATURE After reasonable inquiry and to

View Full Filing

View this SC 13G/A filing on SEC EDGAR